News
HealthDay on MSN37m
FDA Approves Empaveli for Rare Kidney DiseasesThe U.S. Food and Drug Administration has approved Empaveli (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback